Assessment of Dyspnea and Clinical Condition in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
Article Sidebar
Main Article Content
Abstract
Introduction: patients with chronic obstructive pulmonary disease (COPD) are characterized by dyspnea at rest and in activities of daily living.
Objective: to describe the activities that cause greater dyspnea and clinical condition of patients with COPD in a pulmonary rehabilitation program at a clinic in Cali, Colombia.
Material and Methods: descriptive cross-sectional study carried out using non-probabilistic sampling. It was approved by the institutional ethics committee. The variables included in the study were: age, sex, marital status, socioeconomic status, place of residence, health insurance, home oxygen use, emergency room visits and hospitalizations in the last year, GOLD classification, post-bronchodilator spirometry (FEV1, FVC, FEV1 / FVC in percentage of predicted), dyspnea mMRC, weight, height and body mass index (BMI), exposure to wood smoke, tobacco habit, situation or activity in which the greatest perception of dyspnea is triggered, functional capacity, anxiety / depression and health-related quality of life.
Results: 59 participants were enrolled, 36 men (61%), with low socioeconomic status 2 (49.2%). 34 participants (57.6%) used home oxygen, emergency room visits (55.9%). Patients presented greater dyspnea in activities such as climbing stairs (20.3%) and when bathing (16.9%).
Conclusions: patients with COPD had an advanced age with a predominance of males; activities involving the lower extremities and postural muscles such as stair climbing and bathing caused the greatest increase in perceived dyspnea in patients.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Global Iniciative for Chronic Obstructive Lung Disease [GOLD]. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease; 2020. [Internet]. [Consultado 1 oct 2022]. Disponible en: https://goldcopd.org/gold-reports/
Liu Y, Pleasants RA, Croft JB et al. Smoking duration, respiratory symptoms, and COPD in adults aged≥ 45 years with a smoking history. Int J Chron Obstruct Pulmon Dis 2015; 10: 1409-1416. Doi: 10.2147/COPD.S82259
Lee SW, Lyu YR, Park SJ et al. The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Study protocol for randomized, assessor-blind, multicenter trial. Medicine 2020; 99(18): 19826. Doi: 10.1097/MD.0000000000019826
Parshall MB, Schwartzstein RM, Adams L et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185(4): 435-452. Doi: 10.1164/rccm.201111-2042ST
Qian MY, Politis J, Thompson M et al. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD. Respirology 2018; 23(12): 1146-1151. Doi: 10.1111/resp.13324
Prado-Gascó VJ, Pérez-Marín M, Montoya-Castilla I. Chronic respiratory disease questionnaire (CRQ-SAS): Analysis of psychometric properties. Arch Argent Pediatr 2019; 117(3): 149-156. Doi: 10.5546/aap.2019.eng.149
Vaes AW, Delbressine JM, Mesquita R et al. Impact of pulmonary rehabilitation on activities of daily living in patients with chronic obstructive pulmonary disease. J App Physiol 2019; 126(3): 607-615. Doi: 10.1152/japplphysiol.00790.2018
Zeng Y, Jiang F, Chen Y, Chen P, Cai S. Exercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review. Int J Chron Obstruct Pulmon Dis 2018; 13: 2013-2023. Doi: 10.2147/COPD.S167098
Betancourt-Peña J, Benavides-Córdoba V, Avila-Valencia JC, Rosero-Carvajal HE. Differences between COPD patients of a pulmonary rehabilitation program according to the mMRC dyspnea scale. Curr Respir Med Rev 2019; 15(1): 32-38. Doi: 10.2174/1573398X15666190404150703
Holland AE, Spruit MA, Troosters T et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44(6): 1428-1446. Doi: 10.1183/09031936.00150314
Ávila-Valencia JC, Muñoz-Erazo BE, Sarria V, Cordoba VB, Betancourt-Peña J. Cambios en el Bode-Bodex de pacientes con EPOC al culminar un programa de rehabilitación pulmonar. Rev Colomb Rehab 2016; 15(1): 40-47. Doi: 10.30788/RevColReh.v15.n1.2016.7
Terol-Cantero MC, Cabrera-Perona V. Hospital Anxiety and Depression Scale (HADS) review in Spanish Samples. An Psicol 2015; 31(2): 494-503. Doi: 10.6018/analesps.31.2.172701.
Chapeton-Chaves O, Fernández L, Martínez W et al. Validación en español del cuestionario específico para enfermedad respiratoria crónica autodiligenciado (CRQ-AUTOSELF). Rev Colomb Neumol 2016; 28(1): 17-23. Doi: 10.30789/rcneumologia.v28.n1.2016.160
Coccia CB, Palkowski GH, Ntusi NAB, Schweitzer B, Motsohi T. Dyspnoea: Pathophysiology and a clinical approach. S Afr Med J 2016; 106(1): 32-36. Doi: 10.7196/samj.2016.v106i1.10324
Achury-Beltrán LF, Garcia-Peñuela P. Efecto de una actividad grupal educativa en la calidad de vida de la persona con EPOC. Enferm Univ 2019; 16(2): 171-184. Doi: 10.22201/eneo.23958421e.2019.2.649
Cano-Rosales DJ, Bolívar-Grimaldos F, Omaña-Roa JJ, Sepúlveda-Sierra AM. Calidad de vida relacionada con la salud en pacientes con enfermedad pulmonar obstructiva crónica en Hospital Universitario de Santander. Rev Médicas UIS 2017; 30(2): 11-19. Doi: 10.18273/revmed.v30n2-2017001
Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J 2018; 52(5): 1801261. Doi: 10.1183/13993003.01261-2018
Correa S, Gonzaléz M, Betolaza SD et al. Estudio descriptivo de pacientes con EPOC asistidos en medicina interna del Hospital Pasteur de Montevideo: características demográficas y comorbilidades. Rev Urug Med Int 2019; 4(1): 5-15. Doi: 10.26445/04.01.1
Montserrat-Capdevila J, Godoy P, Marsal JR et al. Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers. Aten Primaria 2018; 51(10): 602-609. Doi: 10.1016/j.aprim.2017.10.012
García-García MD, Borge JH, García-García GM, Marquéz-Pérez FL. Supervivencia en pacientes con EPOC en tratamiento con oxigenoterapia continua domiciliaria. Open Respiratory Archives 2021; 3(4), 100119. Doi: 10.1016/j.opresp.2021.100119
Agudelo-Vélez CA, Martínez-Sánchez LM, Ortíz-Trujillo IC et al. Perfil clínico y epidemiológico de pacientes con enfermedad pulmonar obstructiva crónica hospitalizados en un centro de alta complejidad de la ciudad de Medellín, Colombia, durante el año 2015. Investigaciones Andina 2018; 20(37): 151-160.
James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: Is exercise the answer?. Chron Respir Dis 2018; 15(2): 173-181. Doi: 10.1177/1479972317736294
Feldman GJ, Sousa AR, Lipson DA et al. Comparative efficacy of once-daily umeclidinium/vilanterol and tiotropium/olodaterol therapy in symptomatic chronic obstructive pulmonary disease: a randomized study. Adv Ther 2017; 34(11): 2518-2533. Doi: 10.1007/s12325-017-0626-4
Ozsoy I, Kahraman BO, Acar S, Ozalevli S, Akkoclu A, Savci S. Factors influencing activities of daily living in subjects with COPD. Respir Care 2019; 64(2): 189-195. Doi: 10.4187/respcare.05938
Silva CS, Nogueira FR, Porto EF et al. Dynamic hyperinflation during activities of daily living in COPD patients. Chron Respir Dis 2015; 12(3): 189-196. Doi: 10.1177/1479972315576143
Santos KD, Gulart AA, Munari AB, Karloh M, Mayer AF. Ventilatory demand and dynamic hyperinflation induced during ADL-based tests in Chronic Obstructive Pulmonary Disease patients. Braz J Phys Ther 2016; 20: 441-450. Doi: 10.1590/bjpt-rbf.2014.0170